Hospice providers operating under the Medicare benefit face increasing scrutiny from Unified Program Integrity Contractors (UPICs), particularly in regions overseen by Qlarant. These audits are not routine documentation requests—they are focused program integrity investigations designed to identify potential fraud, waste, and abuse (FWA). A poorly managed response can result in claim denials, extrapolated overpayments, payment suspension, or referral to federal enforcement agencies.
For hospice agencies, developing a structured and compliant response strategy is essential to mitigate risk, maintain reimbursement, and protect licensure. This article provides a detailed, field-tested approach to responding to Qlarant UPIC hospice audits, aligned with Medicare Conditions of Participation (CoPs) under 42 CFR Part 418.
Understanding Qlarant UPIC Audits in Hospice
Qlarant, as a UPIC contractor, is tasked with safeguarding the Medicare Trust Fund. Unlike Targeted Probe and Educate (TPE) reviews, UPIC audits are investigative in nature and often triggered by data anomalies such as:
High live discharge rates
Elevated General Inpatient (GIP) utilization
Extended lengths of stay without clinical justification
Patterns of continuous home care billing
Physician certification inconsistencies
These audits frequently involve prepayment or postpayment Additional Documentation Requests (ADRs), and in more serious cases, may escalate to payment suspension or extrapolation.
Phase 1: Immediate Response to the ADR
The moment a Qlarant UPIC ADR is received, the agency must initiate a controlled and coordinated response.
Key Actions:
Confirm Scope of Request
Identify the number of claims requested
Determine audit type (prepayment vs postpayment)
Review submission deadlines (typically 30 days)
Assign a Centralized Audit Lead
Secure and Freeze Records
Failure to meet deadlines or provide complete documentation may result in automatic claim denials.
Phase 2: Comprehensive Documentation Assembly
UPIC reviewers analyze hospice eligibility, medical necessity, and compliance with CoPs. Every submitted record must clearly support terminal prognosis and ongoing eligibility.
Required Documentation Typically Includes:
Physician certification and recertification statements
Face-to-face encounter documentation (if applicable)
Comprehensive assessments
Interdisciplinary Group (IDG) notes
Plan of care (POC) and updates
Visit notes (RN, LVN, CHHA, MSW, Chaplain)
Medication profiles
Hospice election statement
Critical Compliance Standard:
Documentation must demonstrate a life expectancy of six months or less if the illness runs its normal course. This must be supported by clinical evidence, not generalized statements.
Phase 3: Medical Necessity Validation
One of the most common reasons for denials in hospice UPIC audits is failure to substantiate terminal eligibility.
Surveyor Focus Areas:
Decline in functional status (e.g., PPS scores)
Weight loss or nutritional decline
Increased symptom burden
Disease progression markers
Frequency and intensity of skilled nursing needs
Common Deficiencies:
Copy-paste physician narratives
Lack of objective decline indicators
Inconsistent documentation across disciplines
Stable or improving patient conditions without justification
A successful response must create a clear clinical story of decline across all submitted documentation.
Phase 4: Internal Pre-Submission Audit
Before submitting records to Qlarant, agencies should conduct a rigorous internal audit.
Audit Checklist:
Are physician certifications signed, dated, and timely?
Does the narrative align with clinical documentation?
Are IDG notes consistent with the plan of care?
Do visit notes support skilled services and symptom management?
Are recertifications justified with updated clinical data?
This step is critical. Once documentation is submitted, it becomes the basis for audit determinations and potential recoupment.
Phase 5: Submission Strategy and Packaging
UPIC audits are not only about content but also presentation.
Best Practices:
Organize records chronologically
Clearly label each section
Include a cover letter summarizing the clinical justification
Ensure legibility and completeness
Avoid over-submission of irrelevant documents
A well-structured submission improves reviewer efficiency and strengthens the agency’s position.
Phase 6: Post-Submission Monitoring and Response
After submission, agencies must actively monitor for outcomes and prepare for next steps.
Possible Outcomes:
No findings (rare but possible)
Partial claim denials
Full claim denials
Extrapolated overpayment calculations
Payment suspension
Referral to CMS or law enforcement
Agencies must be prepared to respond immediately to determination letters.
Phase 7: Appeals and Defense Strategy
If claims are denied, agencies have the right to appeal through the Medicare appeals process:
Redetermination
Reconsideration
Administrative Law Judge (ALJ) hearing
Medicare Appeals Council
Federal District Court
Critical Considerations:
Appeals must be filed within strict timelines
Clinical arguments must be evidence-based
Expert review may be required
A strong appeal strategy often depends on the quality of the initial submission.
Common Triggers for Qlarant Hospice Audits
Understanding triggers allows agencies to proactively mitigate risk.
High-Risk Indicators:
Long lengths of stay without documented decline
High percentage of dementia diagnoses without supporting evidence
Frequent live discharges followed by re-admissions
Inconsistent physician narratives
Billing patterns deviating from regional norms
Agencies should use internal data analytics to monitor these indicators.
Preventative Compliance Strategies
The best defense against UPIC audits is a proactive compliance program.
Key Components:
1. Robust Documentation Training
Ensure clinicians understand how to document terminal decline and skilled need.
2. Routine Internal Audits
Review charts regularly to identify deficiencies before external audits.
3. Strengthened IDG Oversight
Ensure interdisciplinary alignment and consistent care planning.
4. Physician Engagement
Educate physicians on narrative requirements and eligibility criteria.
5. Data Monitoring
Track key metrics such as length of stay, live discharge rates, and GIP utilization.
Aligning with Hospice Conditions of Participation (CoPs)
UPIC audit success is directly tied to compliance with 42 CFR Part 418.
Key regulatory areas include:
§418.54 Initial and comprehensive assessment
§418.56 Interdisciplinary group, care planning, and coordination
§418.102 Medical director responsibilities
§418.104 Patient care planning
Agencies must demonstrate that documentation and care delivery align with these requirements.
The Financial and Operational Impact of UPIC Audits
UPIC audits can have significant consequences:
Immediate cash flow disruption
Increased administrative burden
Staff burnout
Reputational risk
Potential exclusion from Medicare
A structured response strategy minimizes these risks and protects long-term viability.
How HealthBridge Supports Hospice UPIC Audit Responses
HealthBridge provides specialized support for hospice agencies facing Qlarant UPIC audits.
Our services include:
Full ADR response management
Clinical documentation review and correction guidance
Medical necessity validation
Appeal preparation and strategy
Mock audits and risk assessments
Ongoing compliance program development
We work alongside your team to ensure a defensible, compliant, and strategically sound response that protects both reimbursement and regulatory standing.
Conclusion
Qlarant UPIC hospice audits represent one of the most serious compliance challenges facing Medicare-certified hospice providers. These audits require more than document submission—they demand a strategic, clinically supported, and regulation-aligned response.
Agencies that implement structured audit response protocols, strengthen documentation practices, and proactively monitor risk indicators are best positioned to succeed in these high-stakes reviews.
A well-prepared response not only mitigates financial risk but reinforces the integrity and quality of hospice care delivery.
Medicare & CMS Guidance
